Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C-Dots Nanotec is a Brazilian biotechnology company specializing in the development and production of carbon-based quantum dots, commonly referred to as Carbon Dots. The company utilizes a proprietary platform to synthesize these biocompatible nanoparticles, which serve as high-performance fluorescent markers for bioimaging and molecular diagnostics. Unlike traditional metallic quantum dots, the company's Carbon Dots offer significantly lower toxicity and superior photostability, making them suitable for live-cell imaging and in vivo applications. The technology is a spin-off from research conducted at the University of Campinas (UNICAMP) and the Brazilian Center for Research in Energy and Materials (CNPEM). Beyond healthcare, C-Dots Nanotec explores applications for its nanomaterials in agriculture as tracers and in industrial sectors for anti-counterfeiting measures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on C-Dots Nanotec.